Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians.

Immunoreactive glucagon (IRG) response to a 3 min iv infusion of 25 g glucose was examined in 7 nondiabetic Caucasians, 8 nondiabetic, 8 prediabetic and 16 diabetic Pima Indians to define the normal IRG response and to determine if abnormalities of IRG suppression occur in diabetic and prediabetic Pima Indians. Fasting IRG levels were similar in the 3 nondiabetic groups. In response to the glucose infusion the maximum percentage fall in plasma IRG concentration was similar in the normal Caucasians (37+/-4%) and the normal (42+/-2%) and prediabetic Indians (43+/-3%). In the diabetic Indians the relative fall was less at all sampling times than among the prediabetic or normal Indians. No evidence of any differences in IRG suppression in prediabetic and normal Indians or normal Caucasians was found. Without detectable change in insulin levels during the first 10 min following the glucose infusion, IRG levels in the diabetics fell but to a lesser degree than that in the other groups.

[1]  P. Bennett,et al.  Normal glucagon response to arginine infusion in "prediabetic" Pima Indians. , 1976, The Journal of clinical endocrinology and metabolism.

[2]  P. Bennett,et al.  Arginine-Stimulated Hyperglucagonemia in Diabetic Pima Indians , 1976, Diabetes.

[3]  P. Raskin,et al.  Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. , 1975, The Journal of clinical investigation.

[4]  P. Dunn,et al.  Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics. , 1975, The Journal of clinical endocrinology and metabolism.

[5]  R. Tattersall,et al.  Glucagon secretion in unaffected monozygotic twins of juvenile diabetics. , 1975, Metabolism: clinical and experimental.

[6]  M. Haymond,et al.  Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats. , 1975, The Journal of clinical investigation.

[7]  J. L. Day,et al.  ABNORMALITIES OF GLUCAGON METABOLISM IN DIABETES MELLITUS , 1973, Clinical endocrinology.

[8]  K. Buchanan,et al.  Abnormalities of glucagon metabolism in untreated diabetes mellitus. , 1972, Lancet.

[9]  W. A. Müller,et al.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. , 1970, The New England journal of medicine.

[10]  R. Unger,et al.  Incubation Damage in the Radioimmunoassay for Human Plasma Glucagon and Its Prevention with “Trasylol” , 1968, The American journal of the medical sciences.

[11]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[12]  G. Goldsmith,et al.  Diet Advice to the Healthy Patient: Interpretation of 1964 Recommended Dietary Allowances of the Food and Nutrition Board, National Academy of Sciences-National Research Council , 1964 .

[13]  W. Hoffman.  A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE , 1937 .